Tuesday, July 12, 2011 9:23:50 PM
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the second quarter 2011 on Tuesday, August 2, 2011, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
Interested parties may access the call by dialing 866-277-1181 (in the U.S.) or 617-597-5358 (international), access number 35139244.
A live webcast of the conference call may be accessed in the "Investor Relations" section of www.bio-rad.com. A replay of the call will be available at 888-286-8010 (in the U.S.) or 617-801-6888 (international), access number 87791245, for seven days following the call. The webcast of the call will be archived on the Bio-Rad site for on-demand replay for up to a year and may be accessed in the "Investor Relations" section of www.bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, please visit www.bio-rad.com.
For more information contact:
Christine Tsingos
Vice President and Chief Financial Officer
or
Ron Hutton
Treasurer
Bio-Rad Laboratories, Inc.
510-724-7000
http://ih.advfn.com/p.php?pid=nmona&article=48416154
Recent BIO News
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference • Business Wire • 05/01/2024 01:00:00 PM
- Bio-Rad Announces Life Science Group Management Changes • Business Wire • 04/26/2024 12:30:00 PM
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • Business Wire • 04/18/2024 01:00:00 PM
- Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay • GlobeNewswire Inc. • 04/11/2024 09:30:00 PM
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire • Business Wire • 04/10/2024 08:15:00 PM
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer • Business Wire • 03/20/2024 12:30:00 PM
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day • Business Wire • 02/22/2024 09:30:00 PM
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results • Business Wire • 02/15/2024 09:15:00 PM
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024 • Business Wire • 01/24/2024 10:00:00 PM
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference • Business Wire • 01/02/2024 09:15:00 PM
- Bio-Rad Reports Third-Quarter 2023 Financial Results • Business Wire • 10/26/2023 08:15:00 PM
- Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023 • Business Wire • 10/05/2023 12:30:00 PM
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference • Business Wire • 08/28/2023 08:15:00 PM
- Bio-Rad Reports Second-Quarter 2023 Financial Results • Business Wire • 08/03/2023 08:15:00 PM
- Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement • Business Wire • 07/26/2023 08:15:00 PM
- Bio-Rad Announces New Share Repurchase Program • Business Wire • 07/20/2023 08:30:00 PM
- Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023 • Business Wire • 07/10/2023 08:30:00 PM
- Bio-Rad Publishes Corporate Sustainability Report for 2022 • Business Wire • 07/10/2023 01:00:00 PM
- Bio-Rad to Present Company Overview at Jefferies Healthcare Conference • Business Wire • 06/01/2023 12:00:00 PM
- Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference • Business Wire • 05/08/2023 12:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM